UNSPSC 51183607: Insulin aspart

This classification denotes a therapeutic insulin with the molecular formula C256H381N65O79S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) D933668QVX, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears US NIH Compound Identifier 16129672. European Medicines Agency schedules Insulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02689MIG.

UNSPSC 51183607 Insulin aspart, a Commodity code, covers rapid-acting insulin formulations that state and local governments procure primarily through health agencies, Medicaid programs, and correctional facilities to treat insulin-dependent diabetes in covered populations. The code reflects procurement of a specific pharmaceutical product rather than a broader drug class, and buying patterns reflect standardized dosing, storage, and administration requirements across public health systems.

The source provides no recent state or local contract opportunities under this code. Without posted solicitations or awarded contracts in the available records, the current market activity and geographic distribution cannot be characterized. Agencies purchasing insulin aspart typically do so through standing state Medicaid contracts, cooperative purchasing agreements, or prime vendor arrangements rather than discrete RFPs or RFQs, which may explain limited visibility in public notice databases.